• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Study: Healthcare Industry Embraces Generative AI with Caution

by Fred Pennic 08/06/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Study: Healthcare Industry Embraces Generative AI with Caution

What You Should Know: 

– A new McKinsey survey reveals that the healthcare industry is increasingly recognizing the potential of generative AI (gen AI) to revolutionize patient care and operational efficiency. 

– While a majority of healthcare organizations are exploring or implementing gen AI solutions, concerns about risks and challenges remain.

Report Background

McKinsey conducted two surveys to gather insights from healthcare leaders about their gen AI strategies and plans. The first survey was conducted in December 2023, and the second in March 2024. The surveys included respondents from payers, providers, and healthcare services and technology organizations.

Key Findings:

  • Rapid Adoption: Over 70% of healthcare organizations are actively pursuing or have already implemented gen AI capabilities.
  • Focus on Proof of Concept: Most organizations are in the early stages of gen AI adoption, evaluating potential benefits and risks.
  • Partnership and In-House Development: Healthcare organizations are divided on their approach to gen AI development, with a preference for partnering with third-party vendors.
  • ROI and Scalability Challenges: While many anticipate positive returns on investment, quantifying the impact of gen AI remains a challenge.
  • Risk Management: Concerns about data privacy, security, and clinical outcomes are major barriers to widespread gen AI adoption.

Gen AI’s Potential in Healthcare

The survey highlights several areas where gen AI can create significant value:

  • Improved Clinical Productivity: Automating routine tasks can free up clinicians’ time for patient care.
  • Enhanced Patient Engagement: Personalized communication and support can improve patient satisfaction and outcomes.
  • Increased Operational Efficiency: Streamlining administrative processes can reduce costs and improve overall efficiency.

However, realizing these benefits requires careful planning and risk mitigation. Healthcare organizations must invest in robust governance frameworks, data management strategies, and employee training to ensure the safe and effective use of gen AI.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Generative AI

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |